285. Rhythm and Resilience: A Compilation of Heart Failure Topics in Cardio-Oncology

About This Session

While cardio-oncology encompasses the full spectrum of cardiovascular disease, heart failure remains central to its practice. This case-based session highlights some of the most critical and emerging concepts in the field, moving beyond the traditional focus on LV dysfunction during cancer therapy. Topics include HFpEF, the evolving strategy of permissive cardiotoxicity, novel approaches to cardioprotection, and the integration of artificial intelligence and technology in patient care

Panelists

• Richard Kar-Hang Cheng | Co-Chair
• Anita Descale | Co-Chair
• Courtney Campbell | Panelist
• Jo Rodgers | Panelist
• Vijay Rao | The Heart Wants What It Can't Handle: HFpEF in Cardio-Oncology
• Michelle Bloom | Toxic, but Make It Therapeutic: Permissive Cardiotoxicity
• Jenica Upshaw | Harder, Better, Faster, Stronger: AI/Technology to Detect Cancer Therapy Cardiac Related Dysfunction
• Aba Varac | Umbrella: Cardioprotection During Treatment